Atlas Trials

A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Clinical trial NCT03562156 · COMPLETED

Trial details

NCT number
NCT03562156
Sponsor
Mycovia Pharmaceuticals Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Vulvovaginal Candidiasis
Start date
2018-08-16
Primary completion
2020-10-19
Enrollment
438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.